We participated in AASLD (American Association for the Study of Liver Diseases) 2024.

AASLD (American Association of Liver Diseases) 2024 was held in San Diego from November 15th (Friday) to November 19th (Tuesday), 2024. Lecturer Kota Tsuruta gave a presentation on two topics, "Impact of lipophilicity and daily dose on drug-induced liver injury in the Japanese cohort" and "Pemafibrate improves liver function with alteration of bile acid composition in patients with steatotic liver disease", and Assistant Professor Yusuke Mishima gave a presentation on "Liver-specific FXR deletion with human-like bile acid composition mice by in vivo gene editing using adeno-associated virus and CRISPR/Cas9 System". The discussions were lively, making it a very meaningful conference to attend.